Further, hypomethylation of the CDH3 promoter has been found in addition to (and the cause of) increased expression of CDH3 in both breast cancer (Paredes et al., 2005) and advanced colorectal cancer (Hibi et al., 2009). Here, CDH3 is linked to colorectal cancer.